Rob Dillard

DocwireNews

For cancer patients hospitalized with <a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/covid-19-update-enough-people-have-to-take-vaccine-for-it-be-effective-cases-in-india-spiking-and-more/">SARS-CoV-2</a> (COVID-19), higher viral load is linked to a greater risk of death, according to a study published in the journal Cell.Researchers two diagnostic tests to measure the amount of SARS-CoV-2 in load in nasal swabs, which they obtained upon admission to three New York City hospitals between March 15 and May 14, 2020. They assessed 1000 patients with active cancer, and 2,914 patients without cancer. Overall, about half of patients with cancer had viral loads juxtaposed to 30% of non-cancer patients. Also, among cancer patients, only those who had received chemotherapy or targeted therapy during the previous six months had significantly higher viral loads.Half of patients with hematologic malignancies had high viral loads, compared to approximately 30% of patients without cancer. Among patients with hematologic malignancies, only those who had received chemotherapy or targeted therapy during the previous six months had significantly higher viral loads than the general inpatient population with COVID-19.According to the results, the in-hospital mortality rate for non-cancer patients was 38.8% among patients with a high viral load, 24.1% among patients with a medium viral load, and 15.3% among patients with a low viral load. Cancer patients showed a similar pattern, with mortality rates of 45.2%, 28.0%, and 12.1%, respectively. High viral loads in patients with cancer were correlated with increased in-hospital mortality than low viral loads. The researchers noted that this finding remained statistically significant, even after adjusting for age, and need for supplemental oxygen within the first few hours of presentation to the emergency department.<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Viral load predicts mortality rate in hospitalized patients with cancer and COVID-19 <a href="https://t.co/bsqpUEdTLO">https://t.co/bsqpUEdTLO</a>
&mdash; Cancer News Network (@cancer_network) <a href="https://twitter.com/cancer_network/status/1306245247903690755?ref_src=twsrc%5Etfw">September 16, 2020</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>&nbsp;&ldquo;As a community, we&rsquo;ve only begun to understand the relationship between SARS-CoV-2 viral load and outcomes,&rdquo; says senior study author Michael Satlin, an assistant professor of medicine in the Division of Infectious Diseases at Weill Cornell Medicine and an assistant attending physician at New York-Presbyterian/Weill Cornell Medical Center via a <a href="https://www.eurekalert.org/pub_releases/2020-09/cp-vlp091620.php">press release</a>. &ldquo;Currently, this quantitative information is not given to patient care teams, and providers only know if a patient&rsquo;s test is positive or negative. Giving this information to providers of patients with cancer who have COVID-19 could help them decide on which patients should receive more intensive monitoring when they are in the hospital and which should receive new antiviral medicines if these treatments are in short supply.&rdquo;

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

HER2 Breast Cancer

Trodelvy Plus Keytruda Significantly Improves Progression-Free Survival in PD-L1+ mTNBC, Phase III Data Show

Triple-Negative Breast Cancer

Latest News

Cancer Patients Hospitalized with a High Viral Load of COVID-19 Have a Greater Risk of Dying

COVID-19

For cancer patients hospitalized with SARS-CoV-2 (COVID-19), higher viral load is linked to a greater risk of death, according to a study published in the journal Cell. ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe